AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2025
Nov 17, 2025
34576_dirs_2025-11-17_256d76f5-d5e1-49f8-926c-6f50fdd48698.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2025-11-13
Reporting Person: Wettig Thane (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-13 | Common Stock | P | 1000 | $9.18 | Acquired | 22239 | Direct |
| 2025-11-17 | Common Stock | P | 2700 | $9.0999 | Acquired | 24939 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 40 | Indirect |
More from FIBROGEN INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 15
Regulatory Filings
2026
Jun 9
Delisting Announcement
2026
Apr 9
Call Transcript
2026
Mar 16
Call Transcript
2026
Mar 11
Call Transcript
2026
Feb 26
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Board/Management Information
2026
Jan 7
Director's Dealing
2025
Dec 9